Introduction {#s1}
============

Pseudohypoaldosteronism type II (PHAII) is an autosomal-dominant disease characterized by hypertension due to increased renal salt reabsorption, hyperkalemia and metabolic acidosis ([@b11]; [@b33]; [@b1]). Mutations in with-no-lysine kinase 1 (WNK1) and with-no-lysine kinase 4 (WNK4) have been reported to cause PHAII ([@b42]). We generated WNK4^D561A/+^ knock-in mice, an ideal mouse model of PHAII, and observed increased phosphorylation of oxidative stress-responsive kinase-1 (OSR1), STE20/SPS1-related proline/alanine-rich kinase (SPAK) and thiazide-sensitive Na-Cl co-transporter (NCC) ([@b44]). We previously demonstrated in in vitro experiments that WNK1 and WNK4 phosphorylated and activated OSR1 and SPAK kinases, and that OSR1 and SPAK could phosphorylate NCC ([@b17]; [@b40]; [@b41]; [@b26]). Furthermore, Pacheco-Alvarez et al. reported that phosphorylation of NCC at Thr 53 and 58, and at Ser 71 was important for NCC function in *Xenopus* oocytes ([@b22]), and we showed that phosphorylated NCC is concentrated on the apical membranes of distal convoluted tubules in the WNK4^D561A/+^ knock-in mice, which suggests that phosphorylation may also be important for intracellular localization of NCC ([@b44]). Based on the above evidence, we postulated that WNK, OSR1/SPAK and NCC constitute a signal cascade in the in vivo kidney, which is important for NaCl homeostasis and blood pressure regulation. Recently, we mated WNK4^D561A/+^ knock-in mice with SPAK and OSR1 kinase-dead knock-in mice, in which the T-loop Thr residues in SPAK (Thr 243) and OSR1 (Thr 185) were mutated to Ala to prevent activation by WNK kinases ([@b25]). In these triple knock-in mice, PHAII phenotypes and increased phosphorylation of NCC were completely corrected ([@b5]). Based on the definitive genetic data, we clearly established the presence of the WNK-OSR1/SPAK-NCC kinase cascade in the in vivo kidney.

Although the signal cascade was established, it remains unclear which WNK kinase is responsible in the kidney. It is also uncertain whether a single dominant WNK kinase is present in each different type of cell, or whether multiple WNKs are present in the same cells and function as a WNK kinase complex, as postulated by Yang, C. L. et al. ([@b43]). In fact, in addition to WNK1 and WNK4, whose mutations cause PHAII, WNK3 mRNA expression was reported to be present in the kidney ([@b13]). Therefore, although WNK3 mutation has not been observed in PHAII, WNK3 could be an important component of WNK kinase-mediated signal cascade in kidney. Previous in vitro data found that WNK3 regulates SLC12A cotransporters. WNK3 was shown to be an activator of Na-K-Cl cotransporter (NKCC1 and 2) and NCC ([@b14]; [@b29]; [@b43]; [@b31]; [@b24]; [@b10]; [@b6]), and a repressor of K-Cl cotransporters (KCC 1-4) ([@b14]; [@b7]), when co-expressed in *Xenopus laevis* oocytes. Similar to WNK1 and WNK4, WNK3 was found to phosphorylate SPAK in *Xenopus laevis* oocytes ([@b24]).

Previously, WNK4 hypomorphic mice and WNK1 heterozygous mice reportedly showed low blood pressure ([@b21]; [@b46]). Therefore, we aimed to determine the contribution of WNK3 to WNK-mediated kidney functions by generating WNK3 knockout mice. The data obtained suggest that WNK3 may not play a major role in the WNK kinase cascade in the kidney.

Results {#s2}
=======

Generation of WNK3 knockout mice {#s2a}
--------------------------------

In order to generate WNK3 knockout mice, we planned to delete exon 2 ([Fig. 1A](#f01){ref-type="fig"}), as exon 2 contains the catalytic domain of mouse WNK3 ([@b13]; [@b39]). We crossed chimeric mice from recombinant ES clones with C57BL/6 mice to produce WNK3 (flox/+) mice. The generation of WNK3 (flox/+) mice was verified by PCR ([Fig. 1B](#f01){ref-type="fig"}). Next, to delete exon 2 from the *Wnk3* gene, we crossed WNK3 (flox/+) female mice with Cre recombinase transgenic male mice. The Cre-mediated excision of exon 2 and Neo cassette was verified by PCR, as shown in [Fig. 1C](#f01){ref-type="fig"}. The absence of WNK3 protein was confirmed by immunoblotting in brain and testis ([Fig. 1D](#f01){ref-type="fig"}). However, due to the low level of WNK3 protein expression in the kidney, WNK3 was not detected by immunoblotting, even in wild-type mouse kidney. To verify that WNK3 is also disrupted in the kidney, we performed RT-PCR of WNK3 and confirmed the absence of WNK3 mRNA in the kidneys of WNK3 knockout mice ([Fig. 1E](#f01){ref-type="fig"}).

![Generation of WNK3 knockout mice.\
**(A)** Targeting strategy for *Wnk3* gene interruption. The diagram shows the targeting construct, the wild-type WNK3 locus, and the targeted locus before and after Cre recombination. Three loxPs were inserted to flank exon 2 and the LacZ-Neo-selective marker. Exon 2 was deleted by mating the flox mice with CAG promoter Cre recombinase mice. **(B)** Verification of homologous recombination by PCR of genomic DNA derived from tails of mice. The primer set is indicated by dotted arrows in A. The 227-bp band and 339-bp band represent the wild-type allele and flox allele, respectively. **(C)** Genotyping PCR after Cre recombination, using a primer set indicated by solid arrows in A. A 516-bp PCR product was specific to the mutant allele. **(D)** Immunoblot of brain, kidney and testis homogenates probed with anti-WNK3 antibody. Absence of WNK3 protein in WNK3 knockout mouse was confirmed by immunoblotting in brain and testis. WNK3 was not detected by immunoblotting, even in wild-type mouse kidney, due to the low level of WNK3 protein expression in the kidney. **(E)** RT-PCR of brain, kidney and testis of wild-type and WNK3 knockout mice.](bio-01-02-120-f01){#f01}

Segmental expression of WNK3 along mouse nephron {#s2b}
------------------------------------------------

First, we aimed to determine where WNK3 is expressed along the mouse nephron, as we had to identify the transporters present in the segment where WNK3 is expressed. It was previously reported that, on immunofluorescence, WNK3 is present in all nephron segments ([@b29]). However, because the same antibody did not work both in immunofluorescence and immunoblotting in our hand, we performed laser capture microdissection (LCM) and RT-PCR in order to confirm segmental expression of WNK3 along nephron. As shown in [Fig. 2](#f02){ref-type="fig"}, we confirmed that WNK3 is expressed in proximal tubules, thick ascending limb of Henle\'s loop (TAL), distal convoluted tubules (DCT) and collecting ducts, where Na/H exchanger 3 (NHE3), NKCC2, NCC and epithelial Na channel (ENaC) are expressed, respectively.

![Segmental expression of WNK3 along mouse nephron.\
Primers for NHE3, NKCC2, NCC and ENaC were used as markers for each segment. WNK3 was positive in proximal tubules, thick ascending limb of Henle\'s loop, distal tubules and collecting ducts of wild type mouse. As a negative control, distal tubules and total kidney homogenate from WNK3 knockout mouse were used. PT, proximal tubule; TAL, thick ascending limb of Henle\'s loop; DCT, distal convoluted tubule; CD, collecting duct.](bio-01-02-120-f02){#f02}

Blood and urine analysis {#s2c}
------------------------

We observed no obvious differences between the WNK3 knockout mice and wild-type littermates in survival, gross physical appearance and organ morphology. There were no significant differences in the plasma K^+^ and levels ([Table 1](#t01){ref-type="table"}). Urine volume and urinary excretion of Na^+^ and K^+^ under normal conditions were not significantly affected in WNK3 knockout mice. To more thoroughly characterize the phenotypes, we fed WNK3 knockout and wild-type mice low-salt (0.01% NaCl) and high-salt (4% NaCl) diets, and monitored urinary Na^+^ and K^+^ excretion, particularly focusing on the transition periods while changing diets. However, as shown in [Fig. 3A--C](#f03){ref-type="fig"}, sodium excretion in the WNK3 knockout mice did not change during the experimental period.

![Urinary excretion of Na^+^ and K^+^ in WNK3 knockout mice.\
There were no significant differences in urine volume **(A)**, urinary Na^+^ excretion **(B)** or K^+^ excretion **(C)** between WNK3 knockout mice (squares, *n* = 8) and their wild-type littermates (circles, *n* = 8). On day 0, mice were switched from low-salt diet (0.01% NaCl) to high-salt diet (4.0% NaCl). Before switching diet, mice were fed low-salt diet for 1 week. n.s. not significant.](bio-01-02-120-f03){#f03}

###### Biochemical analysis of blood from wild-type and WNK3 knockout mice

![](bio-01-02-120-t01)

Blood pressure {#s2d}
--------------

We used a tail-cuff system to measure blood pressure. As shown in [Fig. 4A](#f04){ref-type="fig"}, blood pressure in WNK3 knockout mice did not show any significant differences when compared with wild-type mice under normal diet (109.7±1.6 vs. 111.2±1.6 mmHg, knockout: *n* = 11, wild-type: *n* = 14). However, when mice were fed with low-salt diet, blood pressure in WNK3 knockout mice was lower compared with wild-type mice (105.8±1.1 vs. 110.7±0.7 mmHg, knockout: *n* = 11, wild-type: *n* = 9, *P*\<0.01) ([Fig. 4B](#f04){ref-type="fig"}).

![Lower blood pressure in WNK3 knockout mice fed low-salt diet.\
**(A)** Blood pressure in WNK3 knockout mice under normal diet. Blood pressure was measured using a tail-cuff system. WNK3 knockout mice (*n* = 9) did not show significantly decreased systolic blood pressure, as compared to their wild-type littermates (*n* = 14). **(B)** Blood pressure in WNK3 knockout mice (*n* = 11) under low-salt diet. WNK3 knockout mice showed lower blood pressure, as compared to their wild-type littermates (*n* = 9). \**P*\<0.05. n.s. not significant.](bio-01-02-120-f04){#f04}

Expression and phosphorylation of NCC and NKCC2 were not affected in WNK3 knockout mouse kidney {#s2e}
-----------------------------------------------------------------------------------------------

WNK3 reportedly activates NCC and NKCC2 function when co-expressed in *Xenopus* oocytes. Therefore, we investigated whether expression and phosphorylation of NCC and NKCC2 were decreased in the kidneys of WNK3 knockout mice. However, as shown in [Fig. 5A--B](#f05){ref-type="fig"}, we could not see any significant difference in the protein abundance or the magnitude of phosphorylation of NKCC2 and NCC between WNK3 knockout and wild-type mice under a normal diet. Next, to investigate whether phosphorylation of OSR1 and SPAK was lower due to an absence of WNK3, we examined phosphorylation of OSR1 at 325S and SPAK at 380S, phosphorylation sites for WNK kinases, using phospho-specific antibodies. As shown in [Fig. 5C--D](#f05){ref-type="fig"}, phosphorylation of OSR1 and SPAK at their WNK phosphorylation sites was not lower in kidneys from WNK3 knockout mice.

![Expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice under normal diet.\
**(A)** Representative immunoblots of total- and phosphorylated- NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice. **(B)** Densitometry analyses of expression and phosphorylation of NKCC2 and NCC in kidney from wild-type and WNK3 knockout mice. For densitometry analysis, values (*n* = 15) are expressed as ratios against the average of signals in the wild-type group. There were no significant decreases in the expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice, as compared to wild-type littermates. **(C)** Representative immunoblots of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice. **(D)** Densitometry analyses of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice. For densitometry analysis, values (*n* = 15) are expressed as ratios against the average of signals in the wild-type group. There were no significant decreases in phosphorylation of OSR1 and SPAK in kidneys from WNK3 knockout mice, as compared to wild-type littermates. n.s. not significant.](bio-01-02-120-f05){#f05}

Furthermore, we examined the phosphorylation status of NCC and NKCC2 in WNK3 knockout mice under low-salt diet, since blood pressure in WNK3 knockout mice was lower, when mice were fed with low-salt diet. However, even under low-salt diet, WNK3 knockout mice did not show decreased phosphorylation of either NCC or NKCC2, when compared with wild-type mice ([Fig. 6A--B](#f06){ref-type="fig"}). These results indicated that WNK3 does not play a major role in regulation of NCC and NKCC2 in vivo mouse kidney, in contrast to several over-expression studies in *Xenopus* oocytes. Phosphorylation of OSR1 and SPAK at their WNK phosphorylation sites was not lower in kidneys from WNK3 knockout mice, even under low-salt diet ([Fig. 6C--D](#f06){ref-type="fig"}).

![Expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice fed low-salt diet.\
**(A)** Representative immunoblots of total and phosphorylated NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice fed with low-salt diet. **(B)** Densitometry analyses of expression and phosphorylation of NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. For densitometry analysis, values (*n* = 10) are expressed as ratios against the average of signals in the wild-type group. There were no significant decreases in the expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice, as compared to wild-type littermates, even under low-salt diet. **(C)** Representative immunoblots of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. **(D)** Densitometry analyses of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. For densitometry analysis, values (*n* = 10) are expressed as ratios against the average of signals in the wild-type group. There were no significant decreases in phosphorylation of OSR1 and SPAK in kidneys from WNK3 knockout mice, as compared to wild-type littermates. n.s. not significant.](bio-01-02-120-f06){#f06}

Expression of NHE3 and γ-ENaC in the kidneys of WNK3 knockout mice was not significantly different from that in wild-type mice (supplementary material Fig. S1).

Expression levels of WNK4 were elevated in kidneys of WNK3 knockout mice {#s2f}
------------------------------------------------------------------------

The WNK kinase family phosphorylates and activates OSR1 and SPAK, and activated OSR1 and SPAK kinases phosphorylate NCC. We hypothesized that other WNKs could compensate for the absence of WNK3 in the kidney. To examine this hypothesis, we examine the expression levels of WNK1 and WNK4 in the kidneys of WNK3 knockout mice. As shown in [Fig. 7A--B](#f07){ref-type="fig"}, we found that WNK4 expression was slightly but significantly elevated in kidneys from WNK3 knockout mice, as compared to those from wild-type mice. We also examined WNK1 and WNK4 expression in WNK3 knockout mice fed low-salt diet, as compensation would become clearer when the WNK-OSR1/SPAK-NCC phosphorylation cascade is activated ([@b4]). As expected, under low-salt diet, both WNK1 and WNK4 expression increased significantly in kidneys from WNK3 knockout mice, as compared to wild-type mice ([Fig. 7C--D](#f07){ref-type="fig"}). These results indicate that increased expression of WNK1 and WNK4 compensate for the absence of WNK3 in kidneys from WNK3 knockout mice.

![WNK1 and WNK4 were elevated in kidneys from WNK3 knockout mice fed low-salt diet.\
**(A)** Representative immunoblots of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout mice fed normal diet. **(B)** Densitometry analyses of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout mice fed normal diet. For densitometry analysis, values (*n* = 15) are expressed as ratios against the average of signals in the wild-type group. Expression of WNK4 was elevated in kidneys from WNK3 knockout mice, as compared to wild-type littermates. **(C)** Representative immunoblots of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. **(D)** Densitometry analyses of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. For densitometry analysis, values (*n* = 10) are expressed as ratios against the average of signals in the wild-type group. Expression of WNK1 and WNK4 was elevated in kidneys from WNK3 knockout mice, as compared to wild-type littermates. \**P*\<0.05. n.s. not significant.](bio-01-02-120-f07){#f07}

Discussion {#s3}
==========

One of the major issues in hypertension research is regulation of renal sodium transporters that control sodium reabsorption in the kidney. NKCC2 and NCC are kidney-specific members of the SLC12A family of electroneutral cation-chloride co-transporters ([@b12]; [@b8]). They have been shown to play an important role in regulation of blood pressure and sodium reabsorption in the kidney.

Through analyses using genetically engineered mice, we have established the existence of the WNK-OSR1/SPAK-NCC kinase cascade in the in vivo kidney ([@b44]; [@b4]; [@b5]; [@b21]). To date, several physiological regulators of WNK-OSR1/SPAK-NCC phosphorylation cascade have been reported. We have reported that the WNK-OSR1/SPAK-NCC cascade is activated by low-salt diet and inhibited by high-salt diet, mainly via the action of aldosterone ([@b4]). Angiotensin II has also been shown to be a regulator of their phosphorylation ([@b32]; [@b36]; [@b38]). Thus, WNK-OSR1/SPAK-NCC is a regulator of NaCl homeostasis in the kidney through the renin-angiotensin-aldosterone system. Another vasoactive hormone, vasopressin, was shown to regulate this cascade ([@b23]). We recently demonstrated that insulin is another potent regulator of the WNK-OSR1/SPAK-NCC phosphorylation cascade in the kidney ([@b35]). This discovery is important when considering mechanisms of salt-sensitive hypertension in hyperinsulinemic patients, such as those with metabolic syndrome. Moreover, Vallon et al. and Naito et al. reported that potassium intake and extracellular potassium ions, respectively, regulate this cascade ([@b37]; [@b18]). Taken together, these reports indicate that the WNK-OSR1/SPAK-NCC phosphorylation cascade is very important in kidney, not only for the pathogenesis of PHAII, but also for the homeostatic regulation of sodium, potassium, and blood pressure under various pathophysiological conditions.

Similar to NCC, WNKs, OSR1 and SPAK reportedly regulate NKCC2. OSR1 and SPAK kinases interact with an RFQV motif on NKCC2 and directly phosphorylate NKCC2 in in vitro kinase assays ([@b17]; [@b26]; [@b28]). In addition to OSR1 and SPAK, reduced expression of WNK1 by siRNA inhibits endogenous NKCC1 activity in HeLa cells, measured by ^86^Rb influx assays ([@b3]). WNK3 is another WNK kinase that is reported to regulate NKCC2 as well as NCC. Rinehart et al. reported that WNK3 increases NKCC2 phosphorylation at Thr-184 and Thr-189 residues, which had been identified to be necessary for vasopressin-mediated plasma membrane translocation and activation of NKCC2 in *Xenopus laevis* oocytes ([@b29]). In addition, overexpression of WNK3 in *Xenopus laevis* oocytes leads to the activation of NKCC2, which is dependent upon the interaction of SPAK and OSR1 with one of the three RFx\[V/I\]-motifs that are present in WNK3 ([@b24]; [@b26]). Several other groups have reported that co-expression of NCC with WNK3 in *Xenopus laevis* oocytes increased its transport activity ([@b29]; [@b43]; [@b31]; [@b10]; [@b6]). Therefore, in the kidney, it was expected that WNK3 could regulate sodium reabsorption along the nephron by activating NCC and NKCC2 via phosphorylation of OSR1 and SPAK.

Recently, we re-evaluated the immunolocalization of WNK4 along the mouse nephron. In this study, we confirmed that WNK4 is present in DCT, collecting duct and other segments of the nephron, but not in TAL, where NKCC2 and SPAK are present ([@b20]). The lack of WNK4 protein in TAL is consistent with our observation that increased phosphorylation of NKCC2 is not observed in WNK4 knock-in mice (manuscript in preparation), and the fact that PHAII is sensitive to thiazide, but not to furosemide. This indicates that activation of furosemide-sensitive NKCC2 is not observed in PHAII caused by WNK1 or WNK4 mutation, indicating that WNK1 and WNK4 may not play a major role in regulation of NKCC2 in the kidney, although WNK1 phosphorylates NKCC2 in in vitro kinase assays ([@b3]). Therefore, another WNK kinase could be present in TAL to regulate SPAK and NKCC2. This suggests that WNK3 is a regulator of NKCC2 in the kidney.

In this study, we successfully generated WNK3 knockout mice and analyzed their renal phenotype. However, in contrast to data obtained in the *Xenopus* oocytes system and our expectation that WNK3 is a major regulator of NKCC2, WNK3 knockout mice did not show any decrease in expression and phosphorylation of NKCC2 and NCC. Indeed, urinary excretion of Na^+^ and K^+^ was not significantly affected in WNK3 knockout mice, even though we focused on the transition periods when changing sodium diets. These results suggest that WNK3 is not a powerful regulator of NKCC2 and NCC in the kidney, unlike in *Xenopus* oocytes.

There are several possible explanations as to why expression and phosphorylation of NKCC2 and NCC were not lower in WNK3 knockout mouse kidney. It is possible that the expression level of WNK3 in individual tubular cells was too low to contribute to the overall WNK kinase activity. Our immunoblot data clearly showed that WNK3 protein abundance in kidney was below the detection limit. RT-PCR using dissected nephron segments did not show the presence of preferential expression sites for WNK3 along the nephron. These results suggest that WNK3 does not have a specific role in the kidney, in contrast to the role of WNK4 and kidney-specific WNK1 as regulators of NCC in DCT. Another possibility is that the other WNKs, WNK1 and WNK4, compensated for the absence of WNK3 in the NKCC2- and NCC-expressing nephrons. Considering that 1) phosphorylation of OSR1 and SPAK at their WNK phosphorylation sites was not lower in the kidneys of WNK3 knockout mice, and 2) WNK1 and WNK4 expression levels were slightly higher in the kidneys of WNK3 knockout mice, it is possible that WNK1 and WNK4 compensated for the absence of WNK3. Therefore, the lack of phenotype in the absence of WNK3 in the mouse kidney does not necessarily exclude a potential role for WNK3 in activation of NCC and NKCC2 in vivo. On the other hand, WNK4 hypomorphic mice showed decreased phosphorylation of NCC and lower blood pressure, and other WNKs could not compensate ([@b21]). Therefore, as the absence of WNK3 is compensated for by other WNKs, the role of WNK3 in the regulation of NKCC2 and NCC in vivo may not be substantial. To clarify this issue further, WNK3 and WNK4 double-knockout mouse would be required; however, we have not obtained conditional WNK4 knockout mice to date.

WNK3 knockout mice showed lower blood pressure only when mice were fed low-salt diet, although urinary excretion of Na^+^ was not significantly affected in WNK3 knockout mice. Indeed, consistent with urinary data, WNK3 knockout mice did not show any decrease in expression and phosphorylation of NKCC2 and NCC in the kidney even under low-salt diet. These results clearly indicated that lower blood pressure in WNK3 knockout mice fed low-salt diet is not due to decreased sodium reabsorption in the kidney, but due to the other mechanism(s). Since WNK3 is abundantly expressed in brain, it is possible that the absence of WNK3 in brain might affect neuronal regulatory mechanisms of blood pressure, such as secretion of vasopressin, control of sympathetic nerve activity, etc., although the involvement of WNK3 in such processes has not been investigated. It is also possible that WNK3 knockout mice might have reduced vascular resistance since NKCC1, a substrate of SPAK/OSR1, reportedly regulated tonus of vascular smooth muscles, and decreased blood pressure was in fact in the NKCC1 knockout mouse ([@b2]; [@b16]; [@b9]). Interestingly, similar to WNK3 knockout mice, NKCC1 knockout mice also showed lower blood pressure only when mice were fed with low-salt diet ([@b15]). Moreover, we recently found that SPAK knockout mice showed the reduced aortic contractility with decreased phosphorylation of NKCC1 ([@b45]). Accordingly, we tried to evaluate the phosphorylation status of NKCC1 in aorta of WNK3 knockout mice. Unfortunately, we have not yet detected an apparent decrease of NKCC1 phosphorylation in the aorta of WNK3 knockout mice (data not shown). Since the exact quantification of NKCC1 phosphorylation in tiny mouse aortic tissues by immunoblot is in fact very tricky, further investigation must be required to clarify this issue.

In this study, we generated and analyzed WNK3 knockout mice, focusing on their renal phenotypes. However, we did not observe any significant decreases in expression and phosphorylation of NKCC2 and NCC in the WNK3 knockout mouse kidney. Our results suggest that WNK3 only has a minor role in the regulation of NKCC2 and NCC in the in vivo mouse kidney.

Materials and Methods {#s4}
=====================

Targeted disruption of the *Wnk3* gene {#s4a}
--------------------------------------

For generation of WNK3 knockout mice, we prepared the targeting vector using PCR-amplified segments of the *Wnk3* gene after verifying sequences. The targeting vector was transfected into J1 ES cells by electroporation, as described previously ([@b34]). After selection with 150 µg/ml G418 and 2 µM ganciclovir, correctly targeted ES cell clones were selected by PCR and Southern blotting. Chimeric male mice were bred with C57BL/6 female mice to produce the heterozygous floxed mice, and the neo cassette was then deleted by crossing the mice with CAG-Cre recombinase-expressing transgenic mice ([@b30]). Wild-type controls and WNK3 knockout mice were bred and tail genomic DNA was applied for genotyping by PCR (forward primer; 5′-GATATGTAAGCACTACTACC-3′, reverse primer-A; 5′-TCTAATAGCTCAACTGAGTG-3′, reverse primer-B; 5′-GTTCTCAAGTTCTACATCTC-3′). The mice were raised in a 12-hour day and night cycle, fed with normal rodent diet and plain drinking water. The phenotype of male mice was evaluated at the age of 8--14 weeks. The experiment was approved by the Animal Care and Use Committee of Tokyo Medical and Dental University.

Laser capture microdissection (LCM) and RT-PCR {#s4b}
----------------------------------------------

For LCM, mouse kidneys were cut along the long axis and embedded in Tissue-Tek OCT compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan) and immediately frozen in dry ice. Tissue samples were then immersed in nitrogen oxide. Frozen tissue blocks were cut into 10-µm sections, and were mounted on uncoated, uncharged glass slides. Sections were stained for 20 s in Histogene Staining Solution (Arcturus, Mountain View, CA, USA), subjected to dehydration in a graded alcohol series, cleared for 5 min in fresh xylene, and air-dried for 5 min. LCM was performed using a Pixcell II laser capture system (Arcturus). Tubular cells in each nephron were visualized and captured using CapSure LCM macrocaps (Arcturus). Laser setting ranged between 70 to 90 mW in power and 0.6 to 1.0 ms in duration. Total RNA from LCM samples was extracted from captured cells using a PicoPure RNA Isolation kit (Arcturus) and total RNA from mouse kidneys was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer\'s instructions. Total RNA was reverse-transcribed using Omniscript reverse transcriptase (Qiagen, Hilden, Germany). We confirmed the presence of nephron cells using region-specific primers; NHE3 (sense; 5′-GCTGTCATTGGCACTATATGG-3′ (exon 2) and antisense; 5′-GAGGACTTCATTGACATGGAC-3′ (exon 3)), NKCC2 ((sense; 5′-AACTCAGTGCCCAGTAGTGC-3′ (exon 2) and antisense; 5′-AGGCATCCCATCTCCATTAG -3′ (exon 3)), NCC ((sense; 5′- GTCATCATGGTCTCCTTTGC -3′ (exon 7) and antisense; 5′-TAGCTGAGATGGCAAGGTAG-3′ (exon 9)), and ENaC α subunit (sense; 5′-TCAACATTCTGTCCAGACTGC-3′ (exon 3) and antisense; 5′-GTAGCATGGCCCATACATGG-3′ (exon 4)). Finally, we investigated the presence of WNK3 in these tissues; WNK3 (sense; 5′-GCTGTTGCAACTTCCCCTAGT-3′ (exon 1) and antisense; 5′-CCGTTGCTGCTCAGCTTTAG-3′ (exon 2)).

Blood and urine analysis and blood pressure measurement {#s4c}
-------------------------------------------------------

Blood for electrolyte analyses was obtained from the submandibular venous plexus under light ether anesthesia. Electrolyte levels were determined with an i-STAT analyzer (Fuso, Osaka, Japan). Mice were kept in metabolic cages for urine collection. Low-salt (0.01% NaCl) and high-salt (4% NaCl) diets were obtained from Oriental Yeast Co., Ltd. (Tokyo, Japan). Urine samples were analyzed by DRI-CHEM (Fujifilm, Tokyo, Japan). Blood pressure in restrained conscious mice at steady state was measured with a programmable tail-cuff sphygmomanometer (MK-2000A; Muromachi, Tokyo, Japan).

Antibodies {#s4d}
----------

We prepared an affinity-purified sheep antibody raised against a fragment of recombinant mouse WNK3 (residues 1145 -- 1508). Primary antibodies used in this study were: rabbit anti-WNK1 (1:250) (Bethyl Laboratories, Montgomery, TX, USA); rabbit anti-WNK4 (1:250) ([@b20]); rabbit anti-phosphorylated OSR1 (1:3000) ([@b21]); rabbit anti-phosphorylated SPAK (1:500) ([@b45]); rabbit anti-NHE3 (1:200) (Alpha Diagnostic, San Antonio, TX, USA); rabbit anti-phosphorylated NCC (1:250) ([@b44]); guinea pig anti-NCC (1:500) ([@b19]), rabbit anti-phosphorylated NKCC2 (1:500) ([@b45]); rabbit anti-NKCC2 (1:1000) (kindly provided by K. Mutig, Charité-Universitätsmedizin Berlin, Campus Charité-Mitte, Germany); and rabbit anti-ENaC γ subunit (1:250) (kindly provided by M. Knepper, National Institutes of Health, USA). Alkaline-phosphatase-conjugated anti-IgG antibodies (Promega, Madison, WI, USA) were used as secondary antibodies for immunoblotting.

Immunoblotting {#s4e}
--------------

Semiquantitative immunoblotting was performed as described previously using whole kidney homogenates without the nuclear fraction (600 × g) or the crude membrane fraction (17000 × g) ([@b44]). Band intensity was analyzed using Image J (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis {#s4f}
--------------------

Statistical significance was evaluated using unpaired *t*-test. P-values \<0.05 were considered to be significant.

Supplementary Material
======================

###### Supplementary Material

We thank C. Iijima for help in the experiments. We thank K. Mutig and M. Knepper for provision of antibodies. This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research on Creative Scientific Research from the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan-Taiwan Joint Research Program for Interchange Association Japan, the Salt Science Research Foundation (NO. 1026), Takeda Science Foundation, Kanae Foundation for the Promotion of Medical Science, and The Nakajima Foundation.

**Competing interests:** The authors declare no competing interests.
